Sales decline 51.77% to Rs 5.31 crore
Net loss of Bharat Immunological & Biological Corporation reported to Rs 2.39 crore in the quarter ended September 2017 as against net profit of Rs 1.55 crore during the previous quarter ended September 2016. Sales declined 51.77% to Rs 5.31 crore in the quarter ended September 2017 as against Rs 11.01 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales5.3111.01 -52 OPM %-44.6322.16 -PBDT-2.132.58 PL PBT-2.272.47 PL NP-2.391.55 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
